BIO Testimony on “Medicines and IP: Balancing Innovation and Access” to the Subcommittee on Intellectual Property, Artificial Intelligence, and the Internet

Dear Colleagues,  I am just past the two-year mark as BIO’s President & CEO, which arrives as we find ourselves at a defining moment for the future of biotechnology. For fifty years, our industry has delivered one of the great…